Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer
Clinical trial NCT05106296 · RECRUITING
Trial details
- NCT number
- NCT05106296
- Sponsor
- Theodore S. Johnson
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-08
- Primary completion
- 2028-03-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.